Skip to main content
Log in

A Multi-Component Intervention to Improve Therapeutic Adherence in Uncontrolled Hypertensive Patients Within the Primary Care Level: A Before-and-After Study

  • Original article
  • Published:
High Blood Pressure & Cardiovascular Prevention Aims and scope Submit manuscript

Abstract

Introduction

Non-adherence to medication severely affects chronic disease control.

Aim

To assess whether a multi-component intervention implemented at the public primary care level in Argentina improves adherence to antihypertensive medication and helps to reduce blood pressure (BP) levels in uncontrolled hypertensive patients.

Methods

A before-and-after study was conducted in five public primary care clinics located in the city of Almirante Brown, Argentina. One hundred and twenty-five uncontrolled hypertensive patients received a multi-component intervention based on the Chronic Care model and the 5As strategy (Ask, Advise, Agree, Assist, and Arrange). Medication possession ratio (MPR) and BP values were assessed before and after a 6-month period.

Results

The follow-up rate was 96.8%. Main baseline characteristics were as follows, male: 44.8%, mean age: 57.1 years (± 8.1), exclusive public healthcare coverage: 83.5%, primary school level or less: 68.8%, and mean systolic/diastolic BP: 157.4 (± 13.6)/97.7 (± 8.2) mmHg. After implementing the intervention, a significant increase in the proportion of adequate adherence (MPR ≥ 80%) was observed, from 16.8% at baseline to 47.2% (p < 0.001). A significant reduction of 16.4 mmHg (CI 95%: 19.6, 13.1) was observed for systolic blood pressure (SBP) and 12.0 mmHg (CI 95%: 14.2, 9.9) for diastolic blood pressure (DBP) (p < 0.001). At 6 months, 51.2% of the population achieved blood pressure control (SBP < 140 mmHg and DBP < 90 mmHg).

Conclusions

The study intervention was associated with an increased adherence rate, achieving a significant reduction in BP values and reaching BP control in more than half of the population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data Availability

The data that support the findings of this study are available from the corresponding author upon formal request.

References

  1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.

    Article  CAS  PubMed  Google Scholar 

  2. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–14.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Sabaté E. (Ed.) Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization; 2003. https://www.paho.org/en/documents/who-adherence-long-term-therapies-evidence-action-2003. Accessed December 2020.

  4. Ho PM, Magid DJ, Masoudi FA, McClure DL, Rumsfeld JS. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord. 2006;6:48.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, Investigators IS. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52.

    Article  PubMed  Google Scholar 

  6. Cuarta Encuesta Nacional de Factores de Riesgo. Resultados definitivos. 2019. Instituto Nacional de Estadística y Censos (INDEC). Secretaría de Gobierno de Salud de la Nación. República Argentina. https://www.indec.gob.ar/ftp/cuadros/publicaciones/enfr_2018_resultados_definitivos.pdf. Accessed August 2021.

  7. Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96(4): e5641.

    Article  PubMed  Google Scholar 

  8. Manterola C, Otzen O. Estudios Experimentales 2ª Parte. Estudios Cuasi-Experimentale. Int J Morphol. 2015;33(1):382–7.

    Article  Google Scholar 

  9. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111(5):697–716.

    Article  PubMed  Google Scholar 

  10. Topouchian J, Agnoletti D, Blacher J, Youssef A, Ibanez I, Khabouth J, Khawaja S, Beaino L, Asmar R. Validation of four automatic devices for self-measurement of blood pressure according to the international protocol of the European Society of Hypertension. Vasc Health Risk Manag. 2011;7:709–17.

    PubMed  PubMed Central  Google Scholar 

  11. Takahashi H, Yoshika M, Yokoi T. Validation of three automatic devices for the self-measurement of blood pressure according to the European Society of Hypertension International Protocol revision 2010: the Omron HEM-7130, HEM-7320F, and HEM-7500F. Blood Press Monit. 2015;20(2):92–7.

    Article  PubMed  Google Scholar 

  12. Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK. Medication compliance and persistence: terminology and definitions. Value Health J Int Soc Pharmacoecon Outcomes Res. 2008;11(1):44–7.

    Article  Google Scholar 

  13. Anghel LA, Farcas AM, Oprean RN. An overview of the common methods used to measure treatment adherence. Med Pharm Rep. 2019;92(2):117–22.

    PubMed  PubMed Central  Google Scholar 

  14. Guía de Práctica Clínica Nacional de Hipertensión Arterial. Ministerio de Salud de la Nación; 2019. https://bancos.salud.gob.ar/recurso/guia-de-practica-clinica-nacional-de-hipertension-arterial. Accessed January 2021.

  15. Innovative Care for Chronic Conditions-Organizing and Delivering High Quality Care for Chrinic Noncommunicable Diseases in the Americas; 2013. https://www.paho.org/hq/dmdocuments/2013/PAHO-Innovate-Care-2013-Eng.pdf. Accessed December 2020.

  16. Abordaje Integral de personas con Enfermedades Crónicas. Modelo MAPEC. Preograma REDES. Ministerio de Salud de la Nación; 2016. https://bancos.salud.gob.ar/sites/default/files/2018-10/0000000715cnt-2017-06_mapec.pdf. Accessed December 2020.

  17. Five Major Steps to Intervention (The “5 A’s”). Agency for Healthcare Research and Quality (AHRQ). https://www.ahrq.gov/prevention/guidelines/tobacco/5steps.html. Accessed October 2023.

  18. He J, Irazola V, Mills KT, Poggio R, Beratarrechea A, Dolan J, Chen CS, Gibbons L, Krousel-Wood M, Bazzano LA, Nejamis A, Gulayin P, Santero M, Augustovski F, Chen J, Rubinstein A, Investigators H. Effect of a community health worker-led multicomponent intervention on blood pressure control in low-income patients in Argentina: a randomized clinical trial. JAMA. 2017;318(11):1016–25.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Gulayin PE, Lozada A, Beratarrechea A, Gutierrez L, Poggio R, Chaparro RM, Santero M, Masson W, Rubinstein A, Irazola V. An educational intervention to improve statin use: cluster RCT at the primary care level in Argentina. Am J Prev Med. 2019;57:95–105.

    Article  PubMed  Google Scholar 

  20. Rodríguez Chamorro M, Pérez Merino E, García Jiménez E, Rodríguez Chamorro A, Martínez Martínez F, Faus Dader MJ. Revisión de estrategias utilizadas para la mejora de la adherencia al tratamiento farmacológico. Pharmaceutical Care España. 2014;16(3):110–20.

    Google Scholar 

  21. Carroll JK, Fiscella K, Cassells A, Sanders MR, Williams SK, D’Orazio B, Holder T, Farah S, Khalida C, Tobin JN. Theoretical and pragmatic adaptation of the 5As model to patient-centered hypertension counselling. J Health Care Poor Underserved. 2018;29(3):975–83.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Mohan PJ, Aubrey C, L. M. Systems-based approaches to improving medication adherence. 2016; https://www.researchgate.net/publication/353418526_Systems-based_Approaches_to_Improving_Medication_Adherence. Accessed January 2023.

  23. Kini V, Ho PM. Interventions to improve medication adherence: a review. JAMA. 2018;320(23):2461–73.

    Article  PubMed  Google Scholar 

  24. Lindenfeld J, Jessup M. ‘Drugs don’t work in patients who don’t take them’ (C. Everett Koop, MD, US Surgeon General, 1985). Eur J Heart Fail. 2017;19(11):1412–3.

    Article  PubMed  Google Scholar 

  25. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794–811.

    Article  PubMed  Google Scholar 

  26. Smith ML, Bergeron CD, Ahn S, Towne SD Jr, Mingo CA, Robinson KT, Mathis J, Meng L, Ory MG. Engaging the underrepresented sex: male participation in Chronic Disease Self-Management Education (CDSME) programs. Am J Mens Health. 2018;12(4):935–43.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013;51(8 Suppl 3):S11-21.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Halpern MT, Khan ZM, Schmier JK, Burnier M, Caro JJ, Cramer J, Daley WL, Gurwitz J, Hollenberg NK. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension. 2006;47(6):1039–48.

    Article  CAS  PubMed  Google Scholar 

  29. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105–16.

    Article  CAS  PubMed  Google Scholar 

  30. Mabotuwana T, Warren J, Gaikwad RK, Kennelly J, Kenealy T. Analysis of medication possession ratio for improved blood pressure control—towards a semantic web technology enabled workbench: health care and informatics review online; 2008. https://researchspace.auckland.ac.nz/handle/2292/23181. Accessed March 2024.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pablo Elías Gulayin.

Ethics declarations

Funding

Salud Investiga—Ministerio de Salud de la Nación, Argentina.

Conflict of interest

The authors have no competing interests.

Data availability statement

The data that support the findings of this study are available from the corresponding author upon formal request.

Author contributions

All authors contributed to study conception, data collection, and design. Material preparation and analysis were performed by PG, LG and VI. The first draft of the manuscript was written by PG, and all authors commented on the previous versions of the manuscript. All authors have read and approved the final manuscript.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 125 KB)

Supplementary file2 (DOCX 15 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gulayin, P.E., Gutierrez, L., Pinto, D. et al. A Multi-Component Intervention to Improve Therapeutic Adherence in Uncontrolled Hypertensive Patients Within the Primary Care Level: A Before-and-After Study. High Blood Press Cardiovasc Prev (2024). https://doi.org/10.1007/s40292-024-00645-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40292-024-00645-1

Keywords

Navigation